维普中文期刊产品整合服务
35篇 您的检索式:作者名="Mrozikiewicz"
    题名 作者 年代 出处 被引量
1Hormone-balancing and pharmacological effects of therapeutic doses of Lepidium peruvianum (Maca-GO) in poslmenopausal women 显示文摘MEISSNER HO REICH -BILINSKA H MROZIKIEWICZ R 2005Menopause2005,12,6:1
2Blood levels of alloxan in children with insulin- dependent diabetes mellitus 显示文摘Mrozikiewicz A Kielstrokczewska-Mrozikiewicz D Lstroko- wicki Z 1994Acta Diabetol1994,31,4:1
3Quantitative determination of MDR1 mRNA expression in peripheral blood lymphocytes:a possible role of genetic polymorphisms in the MDR1 gene显示文摘Oselin K Nowakowski -Gashaw I Mrozikiewicz PM 2003Eur J Clin Invest2003,33,:1
4Paraoxonase 1 mutations in a Turkish population显示文摘Aynacioglu AS Cascorbi I Mrozikiewicz PM 1999Toxicol Appl Pharmacol1999,157,3:1
5Nadcisnienie ctazowe(GH) a polomorfizm A1166C receptora typu Ⅰ angiotensyny Ⅱ (AT1) 显示文摘Seremak Mrozikiewicz A Drews K Chmara E 2000Ginekol-pol2000,71,8:1
6MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes显示文摘Oselin K Gerlof T Mrozikiewicz PM 2003Fundam Clin Pharmacol2003,17,4:1
7Contribution of maternal-fetal adrenomedullin polymor-phism to gestational hypertension and preedlampsia-gene - gene interaction pilot study 显示文摘Boc Zalewska A Seremak Mrozikiewicz A Barlik M 2012Ginekol Pol2012,83,7:1
8Polymorphism in the genes of toll like receptors type 2 and type 4 (TLR - 2 and TLR - 4) and the risk of premature rup- ture of the membranes prelimina,-y study显示文摘Lukaszewski T Barlik M Seremak -Mrozikiewicz A 2009Ginekol Pol2009,80,:1
9Paraoxonase 1 mutations in a Turkish population显示文摘Aynacioglu AS Cascorbi I Mrozikiewicz PM 1999Toxicology and Applied Pharmacology1999,157,:1
10Arylamine N-acetyltransferase activity in man 显示文摘CASCORBI I BROCKMOLLER J MROZIKIEWICZ PM 1999Drug Metab Rev1999,31,2:1
11Low back pain in pregnant women 显示文摘Majchrzycki M Mrozikiewicz PM Kocur P 2010Ginekol Pol2010,81,11:1
12Homozygous rapid arylamine N- acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer显示文摘Cascorbi I Brockmoller J Mrozikiewicz PM 1996Cancer Res1996,56,17:1
13Peptide nucleic acid-mediated polymerase chain reaction clamping allows allelic allocation of CYP1A1 mutations显示文摘Mrozikiewicz P M Landt O Cascorbi I Roots I 1997Anal Biochem1997,250,:1
14Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population显示文摘Elena A. Gaikovitch Ingolf Cascorbi Przemyslaw M. Mrozikiewicz Jürgen Brockm?ller Roland Fr?tschl Karla K?pke Thomas Gerloff Jury N. Chernov Ivar Roots 2003European Journal of Clinical Pharmacology2003,,4:1
15Importance of CYP1A1 polymorphism and its transcriptional regulation in ovarian and endometrial cancer显示文摘Mrozikiewicz PM Grzeskowiak E Seremak-Mrozikiewicz A 2011Ginekol Pol2011,82,12:1
16Hormone-balancing and pharmacological effects of therapeutic doses of Lepidium peruvianum (Maca-GO) in postmenopausal women显示文摘Meissner HO Reich-Bilinska H Mrozikiewicz R 2005Menopause2005,12,6:1
17Paraoxonase 1 mutations in a Turkish population 显示文摘Aynacioglu AS Cascorbi I Mrozikiewicz PM 1999Toxicol Appl Pharmacol1999,157,:1
18MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes显示文摘Oselin K Gerloff T Mrozikiewicz PM 2003Fundam Clin Pharmacol2003,17,4:1
19Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population 显示文摘Gaikovitch EA Cascorbi I Mrozikiewicz PM Brockmoller J Frotschl R Kopke K 2003Eur J Clin Pharmacol2003,59,4:1
20Importance of CYP1A1 polymorphism and its tran- scriptional regulation in ovarian and endometrial cancer 显示文摘Mrozikiewicz PM Grzeskowiak E Seremak-Mrozikiewicz A 2011Ginekol Pol2011,,12:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费